Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial by Smith, Matthew R, Prof, Saad, Fred, Prof, Coleman, Robert, Prof, Shore, Neal, MD, Fizazi, Karim, Prof, Tombal, Bertrand, Prof, Miller, Kurt, Prof, Sieber, Paul, MD, Karsh, Lawrence, MD, Damião, Ronaldo, Prof, Tammela, Teuvo L, Prof, Egerdie, Blair, MD, Van Poppel, Hendrik, Prof, Chin, Joseph, Prof, Morote, Juan, Prof, Gómez-Veiga, Francisco, MD, Borkowski, Tomasz, Prof, Ye, Zhishen, PhD, Kupic, Amy, MA, Dansey, Roger, MD, Goessl, Carsten, MD

Get full text

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial by Fleshner, Neil E, Prof, Dr, Lucia, M Scott, Prof, Egerdie, Blair, FRCSC, Aaron, Lorne, FRCSC, Eure, Gregg, FACS, Nandy, Indrani, PhD, Black, Libby, PharmD, Rittmaster, Roger S, MD

Get full text